USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling

Open Biol. 2014 May;4(5):140065. doi: 10.1098/rsob.140065.

Abstract

Protein kinase ALK3/BMPR1A mediates bone morphogenetic protein (BMP) signalling through phosphorylation and activation of SMADs 1/5/8. SMAD6, a transcriptional target of BMP, negatively regulates the BMP pathway by recruiting E3 ubiquitin ligases and targeting ALK3 for ubiquitin-mediated degradation. Here, we identify a deubiquitylating enzyme USP15 as an interactor of SMAD6 and ALK3. We show that USP15 enhances BMP-induced phosphorylation of SMAD1 by interacting with and deubiquitylating ALK3. RNAi-mediated depletion of USP15 increases ALK3 K48-linked polyubiquitylation, and reduces both BMP-induced SMAD1 phosphorylation and transcription of BMP target genes. We also show that loss of USP15 expression from mouse myoblast cells inhibits BMP-induced osteoblast differentiation. Furthermore, USP15 modulates BMP-induced phosphorylation of SMAD1 and transcription during Xenopus embryogenesis.

Keywords: ALK3; SMAD; USP15; bone morphogenetic protein; deubiquitylation; ubiquitin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Morphogenetic Protein Receptors, Type I / metabolism*
  • Bone Morphogenetic Proteins / metabolism*
  • Boronic Acids / pharmacology
  • Bortezomib
  • Cell Line
  • Gene Expression Regulation, Developmental
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Mice
  • Phosphorylation
  • Pyrazines / pharmacology
  • Signal Transduction / drug effects
  • Smad1 Protein / metabolism*
  • Ubiquitin-Specific Proteases / metabolism*
  • Ubiquitination
  • Xenopus Proteins / metabolism*
  • Xenopus laevis / embryology*

Substances

  • Bone Morphogenetic Proteins
  • Boronic Acids
  • Pyrazines
  • Smad1 Protein
  • Xenopus Proteins
  • Bortezomib
  • Bone Morphogenetic Protein Receptors, Type I
  • Ubiquitin-Specific Proteases